{"organizations": [], "uuid": "4ab02e5097142dfbdef8f2afab91bad0fc2c7d15", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180418.html", "section_title": "Archive News &amp; Video for Wednesday, 18 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zhejiang-huahai-pharmaceutical-pas/brief-zhejiang-huahai-pharmaceutical-passes-fda-approval-idUSL3N1RV44E", "country": "US", "domain_rank": 408, "title": "BRIEF-Zhejiang Huahai Pharmaceutical passes FDA approval", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.986, "site_type": "news", "published": "2018-04-18T17:55:00.000+03:00", "replies_count": 0, "uuid": "4ab02e5097142dfbdef8f2afab91bad0fc2c7d15"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zhejiang-huahai-pharmaceutical-pas/brief-zhejiang-huahai-pharmaceutical-passes-fda-approval-idUSL3N1RV44E", "ord_in_thread": 0, "title": "BRIEF-Zhejiang Huahai Pharmaceutical passes FDA approval", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-zhejiang huahai pharmaceutical", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "reuters) - zhejiang huahai pharmaceutical co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "u.s food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 18 (Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd\n* Says it received approval for its primary hypertension treatment drug from U.S Food and Drug Administration\nSource text in Chinese: goo.gl/r5pnA6\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/r5pnA6", "https://instagram.com/reuters/"], "published": "2018-04-18T17:55:00.000+03:00", "crawled": "2018-04-19T14:41:07.010+03:00", "highlightTitle": ""}